Probabilistic Steering of Generative Priors for Lab-in-the-Loop Antibody Optimization
arXiv:2611.03844v1 Announce Type: new Abstract: Therapeutic antibody development is often framed as comprising two discrete stages: initial discovery of novel binders followed by iterative optimization to refine these hits into therapeutic-grade molecules. Models and methods often reflect these sta…
Read the full story at arXiv cs.LG ↗
Timeline · 1 report
- 2026-11-04 05:00 · arXiv cs.LG
Probabilistic Steering of Generative Priors for Lab-in-the-Loop Antibody Optimization